Eternis Fine Chemicals Limited and Eternis Fine Chemicals UK Limited have acquired 100% shareholding of Sharon Personal Care, having manufacturing capabilities and innovation labs in Italy and Israel, distribution sites in US, Italy, Germany, and France as well as a global distribution network, from Tene Capital Fund and Burstein Family
DSK Legal advised and assisted Eternis, end-to-end, acting as lead transaction counsel, including in relation to: (a) structuring of the Transaction; (b) facilitating the due diligence of the Sharon PC and its subsidiaries; (c) reviewing, negotiating and finalising the transaction documents; (d) execution and closing of the Transaction; (d) advising on obtaining W&I insurance including review of the W&I insurance policies; and (e) undertaking merger control analysis across multiple jurisdictions.
Aparajit Bhattacharya (Partner) acted as the relationship partner and the lead engagement partner for Eternis on the Transaction.
The transaction team consisted of Aparajit Bhattacharya (Partner), Harvinder Singh (Partner), Shruti Dogra (Associate Partner) and Manhar Gulani (Senior Associate).
The competition team consisted of Abhishek Singh Baghel (Partner), Shivam Sharma (Associate), and Ishan Handa (Associate).
Eternis was also advised by Mayer Brown (London), Goldfarb Gross Seligman (Israel) and PedersoliGattai (Italy) who acted as the foreign legal advisors, conducting legal due diligence on Sharon PC and its subsidiaries.
The sellers, Tene Capital Fund and Burstein Family were represented by Erdinast, Ben Nathan, Toledano & Co.
Eternis, is a wholly owned business of the renowned Mariwala family that has been in the fragrance and flavour industry since decades. Eternis has four manufacturing facilities in the State of Maharashtra (India) as well as a state-of-the-art manufacturing facility acquired in the United Kingdom.
Sharon Personal Care is a global supplier of innovative ingredient solutions for a broad range of personal care products, with specialized expertise in trending market segments.
With this acquisition, Eternis further expands its global footprints, whilst leveraging the multi-location research labs, manufacturing and distribution platforms.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.